OCUL — Ocular Therapeutix Inc. price, chart and key statistics

Price data

Price

$6.65

YTD price return

-45.22%

YTD total return

-45.22%

Next earnings

Nov 3, 2026

Market cap

1.5B2016-12 208.2M2026-10 1.5B+601.3% over the window

Enterprise value

867.4M

Shares outstanding

219.6M2016-06 24.8M2026-06 219.6M+784.8% over the window

52W low

$6.00

52W high

$16.44

From 52W high

-59.55%

From 52W low

+10.83%

52W range

6%

Volume

Rel volume

0.71×

30D volume

3.7M

30D $ vol

29.9M

Fundamentals

Sales (ttm)

52.1M2016-06 1.8M2026-06 52.1M+2850.9% over the window

Sales/share

$0.242016-06 $0.072026-06 $0.24+233.5% over the window

EPS (ttm)

-$1.412018-03 -$1.762026-06 -$1.41-19.8% over the window

FCF (ttm)

-255.1M2016-06 -38.3M2026-06 -255.1M+565.8% over the window

FCF/share

-$1.162016-06 -$1.542026-06 -$1.16-24.7% over the window

Book value/share

$2.372016-06 $2.842026-06 $2.37-16.6% over the window

Net margin

-579.10%2016-06 -2519.6%2026-06 -579.1%-77.0% over the window

ROE

-57.97%2016-06 -63.1%2026-06 -58.0%-8.1% over the window

ROA

-44.90%2016-06 -49.4%2026-06 -44.9%-9.2% over the window

Current ratio

13.112016-06 13.242026-06 13.11-1.0% over the window

Growth (CAGR, ttm) · 10Y

Sales

-8.14%2025-06-30 → 2026-06-3056.7M → 52.1M (-8.1% total)-1.58%2023-06-30 → 2026-06-3054.6M → 52.1M (-4.7% total)+10.03%2021-06-30 → 2026-06-3032.3M → 52.1M (+61.2% total)+40.29%2016-06-30 → 2026-06-301.8M → 52.1M (+2850.9% total)

Shares

+26.24%2025-06-30 → 2026-06-30174M → 219.6M (+26.2% total)+40.37%2023-06-30 → 2026-06-3079.4M → 219.6M (+176.6% total)+23.46%2021-06-30 → 2026-06-3076.6M → 219.6M (+186.8% total)+24.36%2016-06-30 → 2026-06-3024.8M → 219.6M (+784.8% total)

Per-share growth (CAGR, ttm) · 10Y

Sales/share

-27.23%2025-06-30 → 2026-06-30$0.33 → $0.24 (-27.2% total)-29.88%2023-06-30 → 2026-06-30$0.69 → $0.24 (-65.5% total)-10.88%2021-06-30 → 2026-06-30$0.42 → $0.24 (-43.8% total)+12.80%2016-06-30 → 2026-06-30$0.07 → $0.24 (+233.5% total)

Book value/share

+34.71%2025-06-30 → 2026-06-30$1.76 → $2.37 (+34.7% total)+293.30%2023-06-30 → 2026-06-30$0.04 → $2.37 (+5989.4% total)+17.71%2021-06-30 → 2026-06-30$1.05 → $2.37 (+126.0% total)-1.80%2016-06-30 → 2026-06-30$2.84 → $2.37 (-16.6% total)

Price

-45.42%2025-10-20 → 2026-10-20$12.18 → $6.65 (-45.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+41.43%2023-10-20 → 2026-10-20$2.35 → $6.65 (+183.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-10.13%2021-10-20 → 2026-10-20$11.34 → $6.65 (-41.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-0.18%2016-10-19 → 2026-10-20$6.77 → $6.65 (-1.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.

Total return

-45.42%2025-10-20 → 2026-10-20$12.18 → $6.65 (-45.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+41.43%2023-10-20 → 2026-10-20$2.35 → $6.65 (+183.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-10.13%2021-10-20 → 2026-10-20$11.34 → $6.65 (-41.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-0.18%2016-10-19 → 2026-10-20$6.77 → $6.65 (-1.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-4.7×2016-12 -4.902026-10 -4.84-1.1% over the window

Fwd P/E

-4.3×

P/S (ttm)Market cap ÷ TTM revenue.

28.1×2016-12 114.932026-10 28.06-75.6% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

2.8×2016-12 3.342026-10 2.81-16.0% over the window

EV/Sales (ttm)

16.7×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-17.47%2016-09 -17.6%2026-06 -11.8%-32.9% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 219.6M ÷ 174.0M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-26.24%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-26.24%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1.6B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-26.24%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($1.5B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2016-09 0.0%2026-06 0.0%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($1.5B). Same caveat as the cash buyback yield.

0.00%2016-09 0.0%2026-06 0.0%

Vs own 10Y history

P/S

39th

P/B

4th